LDL-2 is a mid-sized LDL particle subfraction — larger than the most atherogenic small dense LDL particles but smaller than LDL-1. It occupies an intermediate position in terms of cardiovascular risk and atherogenicity.
LDL-2 is assessed as part of comprehensive lipid subfraction testing alongside LDL-1 and the small dense LDL particles (sdLDL 1–7). Understanding the distribution of LDL particle sizes provides a more nuanced cardiovascular risk assessment than total LDL cholesterol alone — particularly important for individuals with borderline LDL levels where particle size determines whether the risk is elevated or not.
FAQs
How does LDL-2 differ from LDL-1 and small dense LDL?
LDL particles exist on a size spectrum. LDL-1 is the largest and least atherogenic; small dense LDL (sdLDL) is the smallest and most dangerous. LDL-2 sits between them, with intermediate atherogenicity. Understanding the full distribution is more informative than any single particle measurement.
Is LDL-2 routinely measured?
No. LDL-2 is part of specialised lipid subfraction analysis. It is most useful in cardiovascular risk assessment for people with borderline standard lipids or metabolic syndrome.
What lifestyle changes improve the LDL subfraction profile?
Reducing refined carbohydrates, exercising regularly, losing excess weight, and adopting a Mediterranean or low-carbohydrate diet all shift the LDL subfraction profile toward larger, less atherogenic particles.
Do statins affect LDL-2 levels?
Statins reduce total LDL particle number including LDL-2. They do not dramatically change the relative proportion of small versus large particles, but the absolute reduction in particle count reduces cardiovascular risk.
